IL90462A - Controlled release dosage forms having a defined water content - Google Patents

Controlled release dosage forms having a defined water content

Info

Publication number
IL90462A
IL90462A IL90462A IL9046289A IL90462A IL 90462 A IL90462 A IL 90462A IL 90462 A IL90462 A IL 90462A IL 9046289 A IL9046289 A IL 9046289A IL 90462 A IL90462 A IL 90462A
Authority
IL
Israel
Prior art keywords
controlled release
water content
dosage forms
release dosage
defined water
Prior art date
Application number
IL90462A
Other languages
English (en)
Other versions
IL90462A0 (en
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of IL90462A0 publication Critical patent/IL90462A0/xx
Publication of IL90462A publication Critical patent/IL90462A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL90462A 1988-06-02 1989-05-30 Controlled release dosage forms having a defined water content IL90462A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888813064A GB8813064D0 (en) 1988-06-02 1988-06-02 Controlled release dosage forms having defined water content

Publications (2)

Publication Number Publication Date
IL90462A0 IL90462A0 (en) 1990-01-18
IL90462A true IL90462A (en) 1993-01-31

Family

ID=10637952

Family Applications (1)

Application Number Title Priority Date Filing Date
IL90462A IL90462A (en) 1988-06-02 1989-05-30 Controlled release dosage forms having a defined water content

Country Status (19)

Country Link
US (1) US5091189A (no)
EP (1) EP0344960B1 (no)
JP (1) JPH0816060B2 (no)
KR (1) KR0136279B1 (no)
AT (1) ATE83925T1 (no)
AU (1) AU610401B2 (no)
CA (1) CA1323834C (no)
DE (1) DE68904119T2 (no)
DK (1) DK175130B1 (no)
ES (1) ES2053989T3 (no)
FI (1) FI93695C (no)
GB (2) GB8813064D0 (no)
GR (1) GR3007088T3 (no)
IE (1) IE61998B1 (no)
IL (1) IL90462A (no)
NO (1) NO176232C (no)
NZ (1) NZ229372A (no)
PT (1) PT90722B (no)
ZA (1) ZA894201B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US5912268A (en) * 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
JP2001526228A (ja) 1997-12-22 2001-12-18 ユーロ−セルティーク，エス．エイ． オピオイド作動薬／拮抗薬の併用
RU2228180C2 (ru) * 1997-12-22 2004-05-10 Эро-Селтик, С.А. Способ предотвращения злоупотребления содержащими опиоиды лекарственными формами
WO2000030446A1 (en) 1998-11-23 2000-06-02 Bonnie Davis Dosage formulations for acetylcholinesterase inhibitors
AP1665A (en) 2000-02-08 2006-09-22 Euro Celtique Sa Tamper-resistant oral opioid agonist formulations.
CN1525851A (zh) 2001-05-11 2004-09-01 ������ҩ�����޹�˾ 抗滥用阿片样物质控释剂型
US7052706B2 (en) * 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
WO2003007802A2 (en) * 2001-07-18 2003-01-30 Euro-Celtique, S.A. Pharmaceutical combinations of oxycodone and naloxone
US20030044458A1 (en) * 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
US20030157168A1 (en) * 2001-08-06 2003-08-21 Christopher Breder Sequestered antagonist formulations
IL160222A0 (en) 2001-08-06 2004-07-25 Euro Celtique Sa Opioid agonist formulations with releasable and sequestered antagonist
IN192180B (no) * 2001-09-28 2004-03-06 Ranbaxy Lab
JP2005526079A (ja) * 2002-03-15 2005-09-02 サイプレス バイオサイエンス， インコーポレイテッド 内蔵痛症候群を処置するためのｎｅおよび５−ｈｔ再取り込み阻害剤
SI2425825T1 (sl) 2002-04-05 2017-05-31 Mundipharma Medical Cee Gmbh Farmacevtski pripravek, ki vsebuje oksikodon in nalokson
US7815934B2 (en) * 2002-09-20 2010-10-19 Alpharma Pharmaceuticals, Llc Sequestering subunit and related compositions and methods
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
CA2513893A1 (en) * 2003-01-28 2004-08-12 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
TWI347201B (en) 2003-04-21 2011-08-21 Euro Celtique Sa Pharmaceutical products,uses thereof and methods for preparing the same
EP1604666A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
ATE415148T1 (de) * 2004-10-19 2008-12-15 Krka Tovarna Zdravil D D Novo Feste pharmazeutische zusammensetzung mit donepezilhydrochlorid
EP1702558A1 (en) * 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
ZA200802602B (en) * 2005-08-24 2009-10-28 Rubicon Res Pvt Ltd Controlled release formulation
PT2719378T (pt) 2006-06-19 2016-11-02 Alpharma Pharmaceuticals Llc Composições farmacêuticas
BRPI0717149B1 (pt) * 2006-09-29 2016-02-16 Procter & Gamble composição oral contendo redes de gel e processo para o preparo da mesma.
CA2709992A1 (en) * 2007-12-17 2009-07-16 Alpharma Pharmaceuticals, Llc Abuse resistant pharmaceutical compositions of opiod agonists
US8623418B2 (en) * 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
US20100151014A1 (en) * 2008-12-16 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
US20110177133A1 (en) * 2008-07-07 2011-07-21 Michael Hopp Use of opioid antagonists for treating urinary retention
SG174286A1 (en) 2009-03-10 2011-10-28 Euro Celtique Sa Immediate release pharmaceutical compositions comprising oxycodone and naloxone
NZ716267A (en) 2013-07-23 2017-05-26 Euro Celtique Sa A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
CN114053235B (zh) * 2020-08-07 2023-07-18 广州白云山光华制药股份有限公司 茶碱缓释片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965256A (en) * 1972-05-16 1976-06-22 Synergistics Slow release pharmaceutical compositions
US4443428A (en) * 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
FR2535202B1 (fr) * 1982-11-03 1985-08-09 Fabre Sa Pierre Comprimes de theophylline a liberation controlee et leur procede de fabrication
US4743247A (en) * 1984-08-13 1988-05-10 Alza Corporation Process for manufacturing dosage form
US4753800A (en) * 1985-10-04 1988-06-28 Warner-Lambert Company Medicament adsorbates and their preparation
US4892742A (en) * 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
ES2058111T3 (es) * 1986-06-10 1994-11-01 Euro Celtique Sa Composicion de liberacion controlada de dihidrocodeina.
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids

Also Published As

Publication number Publication date
CA1323834C (en) 1993-11-02
AU610401B2 (en) 1991-05-16
EP0344960B1 (en) 1992-12-30
GB8911629D0 (en) 1989-07-05
ZA894201B (en) 1990-03-28
PT90722B (pt) 1994-11-30
ATE83925T1 (de) 1993-01-15
AU3512789A (en) 1989-12-07
KR0136279B1 (ko) 1998-04-25
EP0344960A3 (en) 1990-03-07
FI892664A0 (fi) 1989-06-01
GR3007088T3 (no) 1993-07-30
IE891744L (en) 1989-12-02
NO176232C (no) 1995-03-01
PT90722A (pt) 1989-12-29
DE68904119D1 (de) 1993-02-11
FI93695B (fi) 1995-02-15
KR900000077A (ko) 1990-01-30
DK175130B1 (da) 2004-06-14
GB8813064D0 (en) 1988-07-06
JPH0816060B2 (ja) 1996-02-21
NZ229372A (en) 1991-07-26
DK266889D0 (da) 1989-06-01
FI892664A (fi) 1989-12-03
IL90462A0 (en) 1990-01-18
JPH0225420A (ja) 1990-01-26
ES2053989T3 (es) 1994-08-01
DE68904119T2 (de) 1993-06-09
DK266889A (da) 1989-12-03
EP0344960A2 (en) 1989-12-06
NO892229L (no) 1989-12-04
GB2219207A (en) 1989-12-06
IE61998B1 (en) 1994-12-14
FI93695C (fi) 1995-05-26
US5091189A (en) 1992-02-25
NO892229D0 (no) 1989-06-01
NO176232B (no) 1994-11-21
GB2219207B (en) 1992-01-02

Similar Documents

Publication Publication Date Title
GB2219207B (en) 3-alkylxanthine containing controlled release dosage forms having a defined water content
IL83363A (en) Use of indol-3-yl-carboxylic acid endo-8-methyl-8-aza- bicyclo (3,2,1) oct-3-yl ester for the preparation of psycho-active pharmaceutical compositions suitable for the treatment of stress- related psychiatric disorders or for increasing vigilance
GB8825024D0 (en) Drug carrier
IL75407A (en) Biodegradable amphipathic copolymers for drug formulations
EP0295903A3 (en) Hair preparation
FR2640505B1 (fr) Preparation pour l'apport de fer, preparation pour l'apport de vitamines et procede pour stabiliser une preparation effervescente
DE3379268D1 (en) 1'-(3-(1,2-benzisoxazol-3-yl)propyl)spiro-(benzofuran-2-(3h),3' or 4'-piperidine or 3'-pyrrolidines), a process for their preparation and their use as medicaments
IT1215332B (it) Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
EP0264744A3 (en) Process for the preparation of 4,4'-diaminodiphenylmethane and its derivatives.
ZA885372B (en) Nutrieut mixture intended for the elderly
GR3007347T3 (no)
EP0334097A3 (en) Process for the preparation of 4,4'-dihalogeno-bisphenyls
FR2518881B1 (fr) Medicaments a base de 26,23-lactones de la 25-hydroxyvitamine d3, utiles notamment pour agir sur la concentration en calcium du serum
EP0269452A3 (en) Use of ketone derivatives for the manufacture of medicaments
HUT53610A (en) Herbicides containing derivatives of 5-(3,4,5,6-tetrahydroftalamid)-cinnamon acid and process for production of the active substances
IT8882523A0 (it) Metodo per l'avanzamento del piede particolarmente nei pedali per velocipedi.
Kuczmann Behaviour of PVC Powder Grains Produced Using Suspension Technology, in Processing
Mahamwal Regulation of foreign investment in India
EP0337789A3 (en) Apparatus for oral administration of a medicament
Haines Hypnotherapeutic reductions of dental patient's distress
Carruthers More to Mitchell; the elusive art of WO Mitchell's Jake and the Kid.
FRANCIS THE MYTH OF" ZINC-FREE" BRONZES
AU8146487A (en) Child's safety seat
AU2590688A (en) Child's chair with safety device
CS440287A1 (en) Device for level height's automatic regulation in crystallizer

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed